相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Corneal Goblet Cells and Their Niche: Implications for Corneal Stem Cell Deficiency
Ahdeah Pajoohesh-Ganji et al.
STEM CELLS (2012)
Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure
Jonathan D. Tung et al.
BMJ OPEN (2012)
Short-term changes in the optic nerve head and visual field after trabeculectomy
M. Figus et al.
EYE (2011)
Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension
L. Jay Katz et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma
A. C. S. How et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Evaluation of Biomarkers of Inflammation in Response to Benzalkonium Chloride on Corneal and Conjunctival Epithelial Cells
Seth P. Epstein et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis
Thomas Hamacher et al.
ACTA OPHTHALMOLOGICA (2008)
Canadian glaucoma study - 2. Risk factors for the progression of open-angle glaucoma
Balwantray C. Chauhan et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4
R. D. Williams et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride
H. Liang et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears
Malik Y. Kahook et al.
CORNEA (2008)
Duration of IOP reduction with travoprost BAK-free solution
Ronald L. Gross et al.
JOURNAL OF GLAUCOMA (2008)
Commercially Available Prostaglandin Analogs for the Reduction of Intraocular Pressure: Similarities and Differences
Gerald W. Bean et al.
SURVEY OF OPHTHALMOLOGY (2008)
Electrophysiological characterization of tight junctional pathway of rabbit cornea treated with ophthalmic ingredients
Tadahiro Nakamura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
In vivo corneal epithelial permeability following treatment with prostaglandin analoges with or without benzalkonium chloride
Bernard McCarey et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
The side effects of the postaglandin analogues
Gabor Hollo
EXPERT OPINION ON DRUG SAFETY (2007)
Travoprost 0.004% with and without benzalkonium chloride: A comparison of safety and efficacy
Richard A. Lewis et al.
JOURNAL OF GLAUCOMA (2007)
Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension
L. B. Cantor et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride
Jess T. Whitson et al.
ADVANCES IN THERAPY (2006)
Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials
PC Maier et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Intraocular pressure-lowering effects of all commonly used glaucoma drugs - A meta-analysis of randomized clinical trials
R van der Valk et al.
OPHTHALMOLOGY (2005)
In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells
JM Guenoun et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension
JS Cohen et al.
SURVEY OF OPHTHALMOLOGY (2004)
Impression cytology of the ocular surface:: a review
M Calonge et al.
EXPERIMENTAL EYE RESEARCH (2004)
A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension
GE Schwartz et al.
SURVEY OF OPHTHALMOLOGY (2004)
Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study
PJ Pisella et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Bimatoprost (Lumigan((R))) is an agonist at the cloned human ocular FP prostaglandin receptor: real-time FLIPR-based intracellular Ca2+ mobilization studies
NA Sharif et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial
A Heijl et al.
ARCHIVES OF OPHTHALMOLOGY (2002)
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension
EJ Higginbotham et al.
ARCHIVES OF OPHTHALMOLOGY (2002)
Bimatoprost and its free acid are prostaglandin FP receptor agonists
NA Sharif et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure
M Sherwood et al.
SURVEY OF OPHTHALMOLOGY (2001)